Amgen (AMGN) Raw Materials (2013 - 2017)

Amgen has reported Raw Materials for 5 years, with the latest figure at $237.0 million in Q2 2017.

• For the quarter ending Q2 2017, Raw Materials changed N/A year-over-year to $237.0 million; the trailing twelve-month figure through Jun 2017 stood at $237.0 million (changed N/A YoY), and the FY2016 full-year result was $225.0 million, up 11.94% from the prior year.
• Raw Materials for Q2 2017 stood at $237.0 million, up from $216.0 million in the prior quarter.
• The five-year high for Raw Materials was $237.0 million in Q2 2017, with the low at $198.0 million in Q4 2014.
• Average Raw Materials over 5 years is $214.4 million, with a median of $216.5 million recorded in 2013.
• Year-over-year, Raw Materials dropped 8.76% in 2014 and gained 11.94% in 2016.
• Tracing AMGN's Raw Materials over 5 years: stood at $217.0 million in 2013, then declined by 8.76% to $198.0 million in 2014, then climbed by 1.52% to $201.0 million in 2015, then increased by 11.94% to $225.0 million in 2016, then gained by 5.33% to $237.0 million in 2017.
• The last three Raw Materials figures came in at $237.0 million (Q2 2017), $216.0 million (Q1 2017), and $225.0 million (Q4 2016), per Business Quant data.

Peer Comparison